Literature DB >> 7615817

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.

D M Bissell1, S S Wang, W R Jarnagin, F J Roll.   

Abstract

Expression of the group of cytokines known as transforming growth factor-beta (TGF-beta 1, -beta 2 and -beta 3) is increased during liver regeneration induced by a 70% partial hepatectomy. The origin of these changes was examined in purified isolates of hepatocytes, sinusoidal endothelial cells, Kupffer cells (liver macrophages), and lipocytes (Ito or stellate cells) from normal and regenerating liver. In normal liver, TGF-beta 1 and -beta 2 levels were relatively high in sinusoidal endothelial cells and Kupffer cells. After partial hepatectomy, an early peak of TGF-beta 2 and -beta 3 was present in all four cell types, followed by a sustained increase in mRNA for TGF-beta 1, -beta 2, and -beta 3 primarily in the hepatocyte population. The specificity of these changes was established by examining a mechanistically different injury model, fibrosis induced by ligation of the biliary duct. In this model, TGF beta mRNA was increased only in lipocytes and the increase was progressive over a 7-d period of observation. Secretion of TGF beta protein was examined in cell isolates placed in short-term primary culture and generally reflected the corresponding mRNA level. The TGF beta released by hepatocytes was entirely in the latent form, whereas the individual nonparenchymal cell isolates released 50-90% active TGF beta. Hepatocyte-conditioned culture medium, after treatment to activate latent TGF beta, inhibited hepatocellular DNA synthesis as did the authentic factor. The data indicate that after injury TGF beta increases selectively in the cells that are the target of the factor, i.e., in hepatocytes after partial hepatectomy and in lipocytes in inflammation and fibrosis. We conclude that the effects of TGF beta in liver regeneration and fibrogenesis are predominantly, if not exclusively, autocrine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615817      PMCID: PMC185218          DOI: 10.1172/JCI118055

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Is there a liver stem cell?

Authors:  S Sell
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

2.  TGF-beta in liver development, regeneration, and carcinogenesis.

Authors:  N Fausto; J E Mead; P A Gruppuso; L Braun
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix.

Authors:  D M Bissell; J M Caron; L E Babiss; J M Friedman
Journal:  Mol Biol Med       Date:  1990-04

4.  Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells.

Authors:  M Matsuoka; N T Pham; H Tsukamoto
Journal:  Liver       Date:  1989-04

5.  Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.

Authors:  D Danielpour; L L Dart; K C Flanders; A B Roberts; M B Sporn
Journal:  J Cell Physiol       Date:  1989-01       Impact factor: 6.384

6.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis.

Authors:  H Nakatsukasa; P Nagy; R P Evarts; C C Hsia; E Marsden; S S Thorgeirsson
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  TGF beta gene transcription in normal and neoplastic liver growth.

Authors:  B I Carr; T H Huang; K Itakura; M Noël; N Marceau
Journal:  J Cell Biochem       Date:  1989-04       Impact factor: 4.429

8.  Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

Authors:  W E Russell; R J Coffey; A J Ouellette; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.

Authors:  M J Czaja; F R Weiner; K C Flanders; M A Giambrone; R Wind; L Biempica; M A Zern
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

10.  Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.

Authors:  R Flaumenhaft; M Abe; P Mignatti; D B Rifkin
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  108 in total

Review 1.  Differential growth: from carcinogenesis to liver repopulation.

Authors:  E Laconi
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

Authors:  J George; S S Wang; A M Sevcsik; M Sanicola; R L Cate; V E Koteliansky; D M Bissell
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 3.  Dendritic cells and immune regulation in the liver.

Authors:  A H Lau; A W Thomson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

4.  Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis.

Authors:  Bo Xu; Ulrika Broome; Mehmet Uzunel; Silvia Nava; Xupeng Ge; Makiko Kumagai-Braesch; Kjell Hultenby; Birger Christensson; Bo-Göran Ericzon; Jan Holgersson; Suchitra Sumitran-Holgersson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

5.  Effects of Zuogui Wan on neurocyte apoptosis and down-regulation of TGF-beta1 expression in nuclei of arcuate hypothalamus of monosodium glutamate -liver regeneration rats.

Authors:  Han-Min Li; Xiang Gao; Mu-Lan Yang; Jia-Jun Mei; Liu-Tong Zhang; Xing-Fan Qiu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 6.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

7.  Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.

Authors:  Yan Li; Lina Lu; Shiguang Qian; John J Fung; Feng Lin
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

8.  Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells.

Authors:  R Jaster; G Sparmann; J Emmrich; S Liebe
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis.

Authors:  N Ohnishi; T Miyata; H Ohnishi; H Yasuda; K Tamada; N Ueda; H Mashima; K Sugano
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

10.  Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Authors:  Tetsuya Shimizu; Shigeki Yokomuro; Yoshiaki Mizuguchi; Yutaka Kawahigashi; Yasuo Arima; Nobuhiko Taniai; Yasuhiro Mamada; Hiroshi Yoshida; Koho Akimaru; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.